CADL vs NWSA · $592.0M cap vs rev $9.03B
Candel Therapeutics Inc (CADL) versus NWSA (NWSA) — a side-by-side from cached financials, not a winner call.
Candel Therapeutics Inc (CADL) is a biotechnology company listed on NASDAQ.
NWSA (NWSA) common stock.
CADL does not have a complete income-statement cache yet.
Latest reported NWSA revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 328.1% from 2025-06-30 to 2026-06-30. NWSA currently screens at market cap $0.
CADL currently screens at market cap $592.0M. NWSA currently screens at market cap $0.
Not investment advice. Open the CADL and NWSA stock pages for the full models.
Not investment advice.